American Society of Hematology

SHERPA: Blue

People

  1. Kernan
    Kernan
  2. O'Reilly
    O'Reilly
  3. Papadopoulos
    Papadopoulos
  4. Castro-Malaspina
    Castro-Malaspina
  5. Scaradavou
    Scaradavou
  6. Young
    Young
  7. Jakubowski
    Jakubowski
  8. Perales
    Perales
  9. Giralt
    Giralt
  10. Ponce
    Ponce

Groups

  1. Pediatrics, Department of (200)
  2. Stem Cell Transplantation and Cellular Therapy Service (200)
  3. Department of Medicine (155)
  4. GSK Faculty (132)
  5. Sloan Kettering Institute Faculty (131)
  6. Immunology Program Faculty (130)
  7. Tow Center for Developmental Oncology (TCDO) (128)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (127)
  9. Center for Hematologic Malignancies (126)
  10. Hematologic Malignancies, Division of (115)
Search Within
  1. "Nancy Kernan"
Formats
  1. Meeting Abstract (161)
  2. Journal Article (39)
Groups
  1. Pediatrics, Department of (200)
  2. Stem Cell Transplantation and Cellular Therapy Service (200)
  3. Department of Medicine (155)
  4. GSK Faculty (132)
  5. Sloan Kettering Institute Faculty (131)
  6. Immunology Program Faculty (130)

More Groups

People
  1. Nancy Kernan (200)
  2. Richard O'Reilly (127)
  3. Farid Boulad (96)
  4. Trudy Small (84)
  5. Esperanza Papadopoulos (79)
  6. Hugo Castro-Malaspina (65)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (3)

More Years

Publications
  1. Blood (195)
  2. Blood Advances (5)

Results (200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
    Journal Article

    Ramaswamy, K.; Steinherz, P. G.; Agrawal, A. K.; Forlenza, C. J.; Mauguen, A.; Roshal, M.; Trippett, T.; Kernan, N. A.; Sulis, M. L.; Shukla, N.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • CD4(+) T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: A dual-center validation
    Journal Article

    de Koning, C.; Prockop, S.; van Roessel, I.; Kernan, N.; Klein, E.; Langenhorst, J.; Szanto, C.; Belderbos, M.; Bierings, M.; Boulad, F.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Racial disparities in access to HLA-matched unrelated donor transplants: A prospective 1312-patient analysis
    Journal Article

    Barker, J. N.; Boughan, K.; Dahi, P. B.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; Mazis, C. M.; Davis, E.; Nhaissi, M.; Wells, D.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save